"Propafenone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
| Descriptor ID |
D011405
|
| MeSH Number(s) |
D02.522.818.830
|
| Concept/Terms |
Rythmol- Rythmol
- Propafenon Minden
- Norfenon
- Pintoform
- Rytmonorm
- Arythmol
|
Below are MeSH descriptors whose meaning is more general than "Propafenone".
Below are MeSH descriptors whose meaning is more specific than "Propafenone".
This graph shows the total number of publications written about "Propafenone" by people in this website by year, and whether "Propafenone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propafenone" by people in Profiles.
-
Burashnikov A, Belardinelli L, Antzelevitch C. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone. J Pharmacol Exp Ther. 2012 Jan; 340(1):161-8.
-
D'Orazio JL, Curtis JA. Overdose of propafenone surreptitiously sold as "Percocet". J Emerg Med. 2011 Aug; 41(2):172-5.
-
Kowey PR, Breithardt G, Camm J, Crijns H, Dorian P, Le Heuzey JY, Pedrazzini L, Prystowsky EN, Salette G, Schwartz PJ, Torp-Pedersen C, Weintraub W. Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. Clin Cardiol. 2010 Mar; 33(3):172-8.
-
Burashnikov A, Antzelevitch C. New pharmacological strategies for the treatment of atrial fibrillation. Ann Noninvasive Electrocardiol. 2009 Jul; 14(3):290-300.
-
Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C. Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation. Ann N Y Acad Sci. 2008 Mar; 1123:105-12.
-
Kowey PR, Yannicelli D, Amsterdam E. Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2004 Sep 01; 94(5):663-5.
-
Kowey PR, Yan GX, Winkel E, Kao W. Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches. Am J Cardiol. 2003 Mar 20; 91(6A):33D-38D.
-
Stevens SK, Haffajee CI, Naccarelli GV, Schwartz KM, Luceri RM, Packer DL, Rubin AM, Kowey PR. Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators. J Am Coll Cardiol. 1996 Aug; 28(2):418-22.
-
Kowey PR, Stohler JL, Friehling TD, Marinchak RA. Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias. Can J Cardiol. 1991 May; 7(4):175-80.
-
Hernandez M, Reder RF, Marinchak RA, Rials SJ, Kowey PR. Propafenone for malignant ventricular arrhythmia: an analysis of the literature. Am Heart J. 1991 Apr; 121(4 Pt 1):1178-84.